» Articles » PMID: 23325613

A Novel SCARB2 Mutation Causing Late-onset Progressive Myoclonus Epilepsy

Citing Articles

Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.

Pavan E, Peruzzo P, Cattarossi S, Bergamin N, Bordugo A, Sechi A Int J Mol Sci. 2024; 25(12).

PMID: 38928321 PMC: 11204053. DOI: 10.3390/ijms25126615.


Genotype-Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature review.

Atasu B, Ozdag Acarli A, Bilgic B, Baykan B, Demir E, Ozluk Y BMC Neurol. 2022; 22(1):122.

PMID: 35346091 PMC: 8962058. DOI: 10.1186/s12883-022-02628-y.


Movement Disorders and Renal Diseases.

Bhowmick S, Lang A Mov Disord Clin Pract. 2020; 7(7):763-779.

PMID: 33043074 PMC: 7534014. DOI: 10.1002/mdc3.13005.


Drug Treatment of Progressive Myoclonic Epilepsy.

Holmes G Paediatr Drugs. 2020; 22(2):149-164.

PMID: 31939107 PMC: 7901803. DOI: 10.1007/s40272-019-00378-y.


Identification of a Novel Homozygous Splice-Site Mutation in that Causes Progressive Myoclonus Epilepsy with or without Renal Failure.

He J, Lin H, Li J, Su H, Wang D, Lin Y Chin Med J (Engl). 2018; 131(13):1575-1583.

PMID: 29941711 PMC: 6032684. DOI: 10.4103/0366-6999.235113.